Transcenta Holding (HKSE:06628) Buyback Yield % : 1.55 (As of Apr. 25, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Transcenta Holding Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Transcenta Holding's current buyback yield was 1.55%.

Transcenta Holding Buyback Yield % Historical Data

The historical data trend for Transcenta Holding's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transcenta Holding Buyback Yield % Chart

Transcenta Holding Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buyback Yield %

Get a 7-Day Free Trial

-15.82

0.17

0.64

Transcenta Holding Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Buyback Yield %	Get a 7-Day Free Trial						0.17	0.01	0.64	1.30	-

Competitive Comparison of Transcenta Holding's Buyback Yield %

For the Biotechnology subindustry, Transcenta Holding's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Transcenta Holding's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transcenta Holding's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Transcenta Holding's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Transcenta Holding Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Transcenta Holding's Buyback Yield for the fiscal year that ended in Dec. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (-10.031	+	0.063)	/	1562.37877
	=	0.64%

Transcenta Holding's annualized Buyback Yield for the quarter that ended in Jun. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (-8.446	+	-0.154)		/	660.03416
	=	1.30%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Transcenta Holding Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Transcenta Holding's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Transcenta Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transcenta Holding Ltd (HKSE:06628) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

B6-501, 218 Xinghu Street, Biobay, Suzhou, CHN, 215123

Website

https://www.transcenta.com

Transcenta Holding Ltd is a clinical-stage biopharmaceutical company with fully integrated capacities in discovery, research, development, and manufacturing. It is developing nine therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. Geographically the company operates in China (the PRC) and the USA.

Executives

Qian Xueming	2101 Beneficial owner
Shi Xiaohong	2501 Other
Lav Corporate Gp, Ltd.	2201 Interest of corporation controlled by you
Lav Gp Iii, L.p.	2201 Interest of corporation controlled by you
Lav Biosciences Fund Iii, L.p.	2101 Beneficial owner
Shi Yi	2201 Interest of corporation controlled by you
Lav Asset Management (hong Kong) Limited	2102 Investment manager
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited
Tls Beta Pte. Ltd.
Hsbc Trust Company (delaware), N.a.	2301 Trustee
Success Link International L.p.	2101 Beneficial owner
Temasek Holdings (private) Limited
Lav Vitality Limited	2101 Beneficial owner
Zhong Guo Guo You Qi Ye Jie Gou Tiao Zheng Ji Jin Gu Fen You Xian Gong Si	2501 Other

Transcenta Holding Headlines

No Headlines